Exploration of Asthma & Allergy
Cure8 research brief
Why This Matters
Measures used in trials and care often miss what patients value most — daily function and quality of life. Learning from IBD and RA could lead to asthma outcome measures and trials that reflect patient priorities, which matters to anyone receiving or studying biologic treatments.
Who Should Pay Attention
Clinicians and researchers working on severe asthma and outcome measurement; patients and patient advocates interested in PROMs and trial design; regulators and industry designing clinical trials for biologics.
Study Snapshot
Story typeResearch paper
Evidence typeResearch paper
Source depthJournal abstract
What To Know
This article (abstract) argues that severe asthma should adopt patient-centred outcome measurement approaches used in rheumatoid arthritis and inflammatory bowel disease — specifically incorporating PROMs and composite scores into trials and routine care.
It highlights initiatives (COMSA, CONFiRM) and past efforts in RA (OMERACT) and IBD (STRIDE) as precedents, and calls for electronic data collection, regulatory acceptance of PROMs, and authentic patient partnership.
Keep In Mind
Structured content depth is “abstract” — the classification and curator note are grounded in the provided abstract rather than a full-paper review. The article uses IBD and RA as examples of fields that integrated PROMs; it is an argument/editorial-style piece advocating measurement changes rather than reporting new trial results.
Source Details
Review the original publication for the complete reporting, methods, and context.
Research paper
Evidence type derived from source or registry metadata.
PublicationExploration of Asthma & Allergy
PublisherOpen Exploration Publishing
AuthorsJoseph W. Lanario, Matthew Masoli, Michael E. Hyland
Study typeJournal Article
Indexed viaCrossref
Source typeResearch paper
PublishedAug 27, 2026, 12:00 AM
Content availableJournal abstract
This Cure8 brief is based on source text from the linked article. Cure8 is informational only and is not a substitute for professional medical advice, diagnosis, or treatment.
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
Retinal microvascular alterations detected by optical coherence tomography angiography in patients with inflammatory bowel disease.
IBD may involve small-vessel changes beyond the gut. If reproducible, retinal microvascular alterations detectable by OCTA could offer a non-invasive window into systemic microvascular involvement in IBD.
Integrating perspectives on transabdominal intestinal ultrasound in inflammatory bowel disease management: a nationwide cross-sectional survey of physicians and patients in China
This survey shows IUS is increasingly recognized but underutilized in China due to limited training and varied perceptions across specialties; patients generally like IUS but many have safety concerns. Addressing...
Crohn᾿s Disease and Ulcerative Colitis: The Role of Endoscopic, Hemogram-derived, Nutritional, and Hepatic Scores
Non-invasive biomarkers that reflect mucosal inflammation and systemic disease activity could help reduce reliance on frequent endoscopy and guide monitoring for people with Crohn’s disease or ulcerative colitis.